← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 22, 2020Last known activity
Sep 17, 2024
Timeline
2010s
- Jun 1, 2016
Repare Therapeutics— Founded
Drugs by trial phase (8 distinct, 10 trials)
Phase 2 (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT06560632Lead sponsorPhase 1Sep 17, 2024
- NCT06232408Lead sponsorPhase 1Feb 14, 2024
- NCT05605509CollaboratorPhase 2Dec 31, 2022
- NCT05566574CollaboratorPhase 1/Phase 2Sep 30, 2022
- NCT05405309CollaboratorPhase 1/Phase 2Sep 23, 2022
- NCT05147350Lead sponsorPhase 1Dec 31, 2021
- NCT05147272Lead sponsorPhase 1Dec 31, 2021
- NCT05147272Study directorPhase 1Dec 31, 2021
- NCT04972110Lead sponsorPhase 1/Phase 2Jul 21, 2021
- NCT04855656Lead sponsorPhase 1Apr 23, 2021
- NCT04497116Lead sponsorPhase 1/Phase 2Jul 22, 2020
Details
- Founded
- Montreal, CA Jun 1, 2016
- Last known activity
- Sep 17, 2024